FDA-Drug2026-07-01Class IIPROCESSING DEFECT
Amgen Sensipar (cinacalcet) 90mg tablets recalled for manufacturing compliance issues
OTHERNationwide distribution
Amgen Sensipar cinacalcet tablets recalled for manufacturing deviations
Amgen is recalling Sensipar (cinacalcet) 90mg tablets due to deviations from current good manufacturing practice (CGMP) standards. This affects one lot distributed nationwide. No injuries have been reported.
- Check if your Sensipar matches lot #1157056 (expiration 02/29/2028).
- Contact your pharmacy or doctor before stopping this medication.
- Return the affected medication to your pharmacy or follow your doctor's instructions.
Hazard
CGMP Deviations
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
1 Amgen Center Dr, N/A, Thousand Oaks, CA, United States
Products
Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, Made in Japan. NDC 55513-075-30
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0616-2026More Amgen, Inc. recalls
- FDA-Drug2026-07-01Amgen Corlanor (ivabradine) 7.5mg tablets recalled for foreign substance
- FDA-Drug2026-07-01Amgen Corlanor (ivabradine) 5 mg tablets recalled for foreign substance contamination
- FDA-Drug2026-07-01Amgen Sensipar 60mg tablets recalled for manufacturing quality deviations
- FDA-Drug2026-07-01Amgen Sensipar (cinacalcet) 30mg tablets recalled for manufacturing quality deviations
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief